Titi Chen

642 total citations
20 papers, 455 citations indexed

About

Titi Chen is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Titi Chen has authored 20 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Titi Chen's work include Immune Cell Function and Interaction (6 papers), Eosinophilic Esophagitis (3 papers) and Renal and related cancers (3 papers). Titi Chen is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Eosinophilic Esophagitis (3 papers) and Renal and related cancers (3 papers). Titi Chen collaborates with scholars based in Australia, China and United States. Titi Chen's co-authors include David C.H. Harris, Qi Cao, Yiping Wang, Vincent Lee, Guoping Zheng, Stephen I. Alexander, Yuan Min Wang, Ruifeng Wang, Chengshi Wang and Xin Maggie Wang and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal Of Pathology.

In The Last Decade

Titi Chen

18 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Titi Chen Australia 10 210 149 101 101 38 20 455
Yaozhong Kong China 13 97 0.5× 296 2.0× 37 0.4× 104 1.0× 51 1.3× 45 568
Takeshi Fujita Japan 12 83 0.4× 86 0.6× 74 0.7× 97 1.0× 68 1.8× 47 421
Maria Bartosova Germany 14 67 0.3× 282 1.9× 191 1.9× 91 0.9× 83 2.2× 37 535
Fengfeng Xu China 9 46 0.2× 169 1.1× 81 0.8× 138 1.4× 63 1.7× 11 416
Francine Brambate Carvalhinho Lemos Brazil 13 110 0.5× 69 0.5× 145 1.4× 112 1.1× 40 1.1× 26 541
Luís Eduardo Becker Germany 13 80 0.4× 87 0.6× 148 1.5× 43 0.4× 34 0.9× 23 436
Florian G. Scurt Germany 9 40 0.2× 88 0.6× 80 0.8× 76 0.8× 49 1.3× 32 360
Markus Pirklbauer Austria 15 42 0.2× 135 0.9× 88 0.9× 130 1.3× 79 2.1× 33 462
Junya Ajiro Japan 10 107 0.5× 151 1.0× 63 0.6× 97 1.0× 16 0.4× 15 501
Panagiotis Pateinakis Greece 10 61 0.3× 208 1.4× 65 0.6× 57 0.6× 52 1.4× 32 410

Countries citing papers authored by Titi Chen

Since Specialization
Citations

This map shows the geographic impact of Titi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Titi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Titi Chen more than expected).

Fields of papers citing papers by Titi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Titi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Titi Chen. The network helps show where Titi Chen may publish in the future.

Co-authorship network of co-authors of Titi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Titi Chen. A scholar is included among the top collaborators of Titi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Titi Chen. Titi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaoxue, Hien Duong, Ping Ye, et al.. (2025). Renal clearable sucrose carbon dots for doxorubicin delivery to treat renal carcinoma. Nanoscale Advances. 7(9). 2751–2760. 1 indexed citations
2.
Cao, Qi, Yiping Wang, Jianwei Chen, et al.. (2025). Targeting inflammation with chimeric antigen receptor macrophages using a signal switch. Nature Biomedical Engineering. 9(9). 1502–1516. 11 indexed citations
3.
Downs, Shauna, Titi Chen, Selena Ahmed, et al.. (2025). The Food Environment Toolbox: Developing and Piloting a Suite of Tools to Measure Food Environments in Low- and Middle-Income Countries. Current Developments in Nutrition. 9(5). 107444–107444.
4.
Cao, Qi, Ruifeng Wang, Zhiguo Niu, et al.. (2023). Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury. JHEP Reports. 5(10). 100837–100837. 6 indexed citations
5.
Chen, Titi, Qi Cao, Ruifeng Wang, et al.. (2023). Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease. Clinical Immunology. 250. 109295–109295. 4 indexed citations
6.
Francis, Anna, Udeme E. Ekrikpo, Titi Chen, et al.. (2022). Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|. Kidney International. 102(5). 969–973. 21 indexed citations
7.
Rao, Padmashree, Xi Qiao, Min Hu, et al.. (2021). Promotion of β-Catenin/Forkhead Box Protein O Signaling Mediates Epithelial Repair in Kidney Injury. American Journal Of Pathology. 191(6). 993–1009. 7 indexed citations
8.
Chen, Titi, Qi Cao, Ruifeng Wang, et al.. (2021). Conventional Type 1 Dendritic Cells (cDC1) in Human Kidney Diseases: Clinico-Pathological Correlations. Frontiers in Immunology. 12. 635212–635212. 5 indexed citations
9.
Chen, Titi, et al.. (2020). The Case | A hidden deposit. Kidney International. 97(4). 815–816.
10.
Yang, Ying, Brian J. Nankivell, Padmashree Rao, et al.. (2020). Renal tubular cell binding of β-catenin to TCF1 versus FoxO1 is associated with chronic interstitial fibrosis in transplanted kidneys. American Journal of Transplantation. 21(2). 727–739. 8 indexed citations
11.
Cao, Qi, Ruifeng Wang, Yiping Wang, et al.. (2019). Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injury. Kidney International. 97(1). 130–142. 35 indexed citations
12.
Rao, Padmashree, Min Pang, Xi Qiao, et al.. (2019). Promotion of β-catenin/Foxo1 signaling ameliorates renal interstitial fibrosis. Laboratory Investigation. 99(11). 1689–1701. 22 indexed citations
13.
Chen, Titi, Qi Cao, Yiping Wang, & David C.H. Harris. (2019). M2 macrophages in kidney disease: biology, therapies, and perspectives. Kidney International. 95(4). 760–773. 145 indexed citations
14.
Wang, Ruifeng, Titi Chen, Chengshi Wang, et al.. (2018). Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation. Nephrology Dialysis Transplantation. 34(11). 1853–1863. 22 indexed citations
15.
Chen, Titi, et al.. (2018). High‐Sensitivity Troponin T and C‐Reactive Protein Have Different Prognostic Values in Hemo‐ and Peritoneal Dialysis Populations: A Cohort Study. Journal of the American Heart Association. 7(5). 31 indexed citations
16.
Cao, Qi, Yiping Wang, Zhiguo Niu, et al.. (2018). Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury. Journal of the American Society of Nephrology. 29(3). 961–976. 104 indexed citations
17.
Chen, Titi, Vincent Lee, & David C.H. Harris. (2018). When to initiate dialysis for end‐stage kidney disease: evidence and challenges. The Medical Journal of Australia. 209(6). 275–279. 9 indexed citations
18.
Chen, Titi & David C.H. Harris. (2015). Challenges of chronic kidney disease prevention. The Medical Journal of Australia. 203(5). 209–210. 21 indexed citations
19.
Chen, Titi, Qi Cao, Yiping Wang, & David C.H. Harris. (2014). The Role of Dendritic Cells in Renal Inflammation. Current Pathobiology Reports. 2(4). 225–234. 1 indexed citations
20.
Chen, Titi, et al.. (2012). Precision of Histological Bone Marrow Staging in Follicular Lymphoma and Diffuse Large B-cell Lymphoma. Clinical and investigative medicine. 35(6). E358–E364. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaozhong Kong Breakdown of academic impact, for papers by Takeshi Fujita Breakdown of academic impact, for papers by Maria Bartosova Breakdown of academic impact, for papers by Fengfeng Xu Breakdown of academic impact, for papers by Francine Brambate Carvalhinho Lemos Breakdown of academic impact, for papers by Luís Eduardo Becker Breakdown of academic impact, for papers by Florian G. Scurt Breakdown of academic impact, for papers by Markus Pirklbauer Breakdown of academic impact, for papers by Junya Ajiro Breakdown of academic impact, for papers by Panagiotis Pateinakis
Rankless by CCL
2026